May 17, 2022 8:00am EDT QSAM Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
April 28, 2022 7:00am EDT QSAM Biosciences Doses First Patient in its Clinical Trial for Cyclosam®, Radiopharmaceutical Drug Candidate for the Treatment of Bone Cancer